908 Devices Inc.

MASS Healthcare Medical Devices

In the quarter to June 2026, revenue grew 23.3%, EPS grew 13.5% and free cash flow grew 151.0%, each against the same quarter a year earlier.

11.33 0.56 −4.71%
Market cap
$491.5M
P/E
0.0×
Fwd P/E
−13.3×
Dividend yield
—
F-score
5/9
Altman Z
1.10
Beneish M
−2.52
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

3 5 4 5
ROE
(3.09%) 15.09% (24.57%) (25.15%)
ROA
(2.24%) 11.15% (18.85%) (17.81%)
ROIC
(152.75%) (80.18%) (115.03%) (96.41%)
Return on Tangible Assets
(3.84%) 16.99% (33.87%) (39.74%)
Average Days of Receivables
75.53 73.57 62.30 70.25
Free Cash Flow per Share
(0.79) (0.69) (0.23) 0.02
Free Cash Flow
(28.40) (24.64) (8.30) 0.62
Capital Expenditures
(1.15) (0.95) (0.84) (0.88)
Other line items
Cash ROIC
(11.44%) (9.60%) (3.38%) 0.27%
Accounts Receivable Turnover
3.84 5.57 6.88 6.79
Accounts Payable Turnover
14.69 18.80 8.96 9.25
Inventory Turnover
1.64 2.33 2.16 1.95
Average Days of Payables
24.29 20.84 31.44 34.00
Days of Inventory on Hand
205.53 170.71 172.37 180.23
Tax Rate
0.00 (0.01) 0.00 0.00
Research and Development Expense of Revenue
30.04% 27.72% 26.33% 23.69%
Selling, General and Administrative Expense of Revenue
75.57% 68.56% 66.09% 64.07%
Share Based Compensation of Revenue
18.63% 17.52% 17.09% 16.20%
Operating CF/Net income
6.60 (1.22) 0.21 (0.04)
Depreciation/Fixed assets
3.47 0.90 0.97 1.02
Capex/Depreciation
(0.08) (0.25) (0.21) (0.19)
Revenue per Share
1.47 1.57 1.57 1.61
Operating CF per Share
(0.75) (0.66) (0.20) 0.04
Capex per Share
(0.03) (0.03) (0.02) (0.02)
Capex to Sales
0.02 0.02 0.01 0.01

Fold the line items

Columns are period end dates